These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

919 related items for PubMed ID: 22161980

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.
    Dodson TB.
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):509-16. PubMed ID: 26362367
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Osteonecrosis of the Jaw.
    Hamdy RC.
    J Clin Densitom; 2017 Nov; 20(1):1-2. PubMed ID: 28259260
    [No Abstract] [Full Text] [Related]

  • 6. Osteonecrosis of the jaw.
    Drozdzowska B.
    Endokrynol Pol; 2011 Nov; 62(1):88-92. PubMed ID: 21365586
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: clinicopathological features of 24 patients.
    Favia G, Pilolli GP, Maiorano E.
    J Rheumatol; 2009 Dec; 36(12):2780-7. PubMed ID: 19884275
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Denosumab, an Alternative to Bisphosphonates but also Associated with Osteonecrosis of the Jaw--What is the Risk?
    Sidhu HK.
    Dent Update; 2015 Jun; 42(5):436-8, 440. PubMed ID: 26964445
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Osteonecrosis of the jaw after oral bisphosphonate for osteoporosis.
    Tong CK, Ho ST, Wong SL.
    Hong Kong Med J; 2010 Apr; 16(2):145-8. PubMed ID: 20354251
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Denosumab and anti-angiogenetic drug-related osteonecrosis of the jaw: an uncommon but potentially severe disease.
    Sivolella S, Lumachi F, Stellini E, Favero L.
    Anticancer Res; 2013 May; 33(5):1793-7. PubMed ID: 23645723
    [Abstract] [Full Text] [Related]

  • 19. Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings.
    Hoefert S, Schmitz I, Tannapfel A, Eufinger H.
    Clin Oral Investig; 2010 Jun; 14(3):271-84. PubMed ID: 19536569
    [Abstract] [Full Text] [Related]

  • 20. Drug-induced osteonecrosis of the jaw: the state of the art.
    Fassio A, Bertoldo F, Idolazzi L, Viapiana O, Rossini M, Gatti D.
    Reumatismo; 2017 May 22; 69(1):9-15. PubMed ID: 28535616
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.